2012

Rödel, F., Sprenger T., Kaina B., Liersch T., Rödel C., Fulda S., Hehlgans S. (2012) Survivin as a prognostic/predictive marker and molecular target in cancer therapy, Current Medicinal Chemistry, 19, 3679-3688

Kaina B., Christmann M., Eich M., Roos W.P. (2012) Survival and death strategies in cells exposed to genotoxins, Issues in Toxicology, No 13, chapter 4.1., 215 et seqq

 

Huelsenbeck S.C., Schorr A., Roos W.P., Huelsenbeck J., Henninger C., Kaina B., Fritz G. (2012) Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons, Journal of Biological Chemistry, 287, 38590-38599




Faust D., Al-Butmeh F., Linz B., Dietrich C. (2012) Involvement of the transcription factor FoxM1 in contact inhibition, Biochemichal and Biophysical Research Communications, 426, 659-663

 

Mosby T.T., Cosgrove M., Sarkardei S., Platt K.L., Kaina B. (2012) Nutrition in adult and childhood cancer: role of carcinogens and anti-carcinogens, Anticancer Research, 32, 4171-4192



Christmann M., Kaina B. (2012) O6 -methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke, Mutation Research, 736, 64-74




Mangerich A., Veith S., Popp O., Fahrer J., Martello R., Bohr V.A., Bürkle A.  (2012) Quantitative analysis of WRN exonuclease activity by isotope dilution mass spectrometry, Mechanisms of Ageing and Development, 133, 575-579

 

Nikolova T., Hennekes F., Bhatti A., Kaina B. (2012) Chloroethylnitrosourea-induced cell death and genotoxicity: cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ, Cell Cycle, 11, 2606-2619

 

Lillich M., Che X., Weil T., Barth H., Fahrer J. (2012) Streptavidin-conjugated C3 protein mediates the delivery of mono-biotinylated RNAse A into macrophages, Bioconjugate Chemistry, 23, 1426-1436

 

Meise R., Tomicic M.T., Kaina B., Christmann M. (2012) The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells, Biochimica et Biophysica Acta, 1823, 1199-1207

 

Bauer M., Goldstein M., Heylmann D., Kaina B. (2012) Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant, PLoS One, 7, e39956

 

Henninger C., Huelsenbeck J., Huelsenbeck S., Grösch S., Schad A., Lackner K.J., Kaina B., Fritz G. (2012) The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity, Toxicology and Applied Pharmacology, 261, 66-73



Döhrmann M., Schorr A., Hülsenbeck J., Rasmussen T.L., Issinger O.G., Fritz G. (2012) Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH, Experimental Cell Research, 318, 779-788

 

Faust D., Schmitt C., Oesch F., Oesch-Bartlomowicz B., Schreck I., Weiss C., Dietrich C. (2012) Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts, Cell Communication and Signaling, 10:6




Albers A.E., Chen C., Koeberle B., Qian X., Klussmann J.P., Wollenberg B., Kaufmann A.M. (2012) Stem cells in squamous head and neck cancer, Critical reviews in Oncology/Hematology, 81, 224-240




Koeberle B., Pieé-Staffa A. (2012) The molecular basis of cisplatin resistance in bladder cancer cells, Interchopen.com, 265-290




Huelsenbeck S.C., Rohrbeck A., Handreck A., Hellmich G., Kiaei E., Roettinger I., Grothe C., Just I., Haastert-Talini K. (2012) C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury, Neurotherapeutics, 9, 185-198